Image

Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency

Study Investigating Investigational Medication for Pancreatic Cancer with Homologous Recombination Deficiency

Recruiting
18-80 years
All
Phase 2/3
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates pancreatic cancer with homologous recombination deficiency. It focuses on evaluating treatments for this condition.

This study evaluates the effectiveness and safety of a specific treatment approach. This study investigates how well the treatment works for patients with the condition.

  • Who can participate: Adults aged 18 to 80 years with advanced pancreatic adenocarcinoma and homologous recombination deficiency can participate. Participants must have experienced tumor progression after at least one line of chemotherapy and meet specific health criteria.
  • Study details: Participants will receive an investigational medication. Some may receive a placebo, an inactive substance that looks like the investigational medicine but does not contain any medicine. The study will measure various health outcomes during participation.
Print
Study details
    Pancreatic Adenocarcinoma
    Homologous Recombination Deficiency

NCT06095141

Fudan University

30 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.